Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sequential Cohort Study Exploring Gelclair in the Management of Oral Mucostitis (OM) in Patients Receiving Radical Radiation for Head and Neck Cancer (GOMS)

NCT06897215 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT06897215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06897215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sequential Cohort Study Exploring Gelclair in the Management of Oral Mucostitis (OM) in Patients Receiving Radical Radiation for Head and Neck Cancer (GOMS)
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 1, 2025
Completion date
December 31, 2025
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis due to radiation